Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

10.85
Delayed Data
As of 3:58pm ET
 -0.015 / -0.14%
Today’s Change
8.10
Today|||52-Week Range
19.05
-15.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues16.0K12.0K6.9M3.0K
 
 
 
 
 
Cost of Goods Sold----1.0M0.00
 
 
Depreciation And Amortization24.0K24.1K26.6K36.0K
 
 
 
 
 
 
Operating ExpensesGross Income----5.9M-33.0K
 
 
 
General Expenses9.0M10.8M16.5M21.9M
 
 
 
 
 
Research And Development6.5M8.1M12.5M17.8M
 
 
 
 
 
Total Operating Expenses9.1M10.8M17.5M21.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.0M-10.8M-10.6M-21.9M
 
 
 
 
 
Extraordinary Credit57.0K54.1K197.2K887.7K
 
 
 
 
 
Extraordinary Charge0.000.00---100.0K
 
 
Other Expenses-1.3M90.2K-279.0K-211.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.3M-10.7M-10.6M-21.1M
 
 
 
 
 
Net Income-10.3M-10.7M-10.6M-21.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.3M6.2M8.7M11.1M
 
 
 
 
 
Shares To Calculate EPS Diluted5.3M6.2M8.7M11.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.00-$1.70-$1.18-$1.90
 
 
 
 
 
EPS Diluted-$2.00-$1.70-$1.28-$1.90